Barely Significant
← all excerpts

Harnessing metabolomics and proteomics in a clinical trial for pulmonary arterial hypertension: insights from post-hoc analysis of the REHAB-PH trial.

EBioMedicine · 2026 · PMC13014658 · PMID 41849831

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

nominally significantp < 0.05actually significant
23 , 24 , 25 , 26 Ten of the leading-edge proteins contributing to the core enrichment showed nominally significant downregulation (p < 0.05) further suggesting a coordinated suppression of RTK activity with famotidine use ( Supplemental Figure S3 ).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.